An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.

Dr. Ibon Garitaonandia, MBA, is the chief scientific officer at CellProthera, a clinical-stage biotech developing stem cell therapy for ischemic heart disease. In this article, Garitaonandia discusses ...

Formation of human myocardium in the rat heart from human embryonic stem cells. Am. J. Pathol. 167(3), 663-671 (2005). Perin EC: The use of stem cell therapy for cardiovascular disease.

Explore the safety concerns and potential benefits of stem cell therapies as researchers warn against unproven treatments.

The EHM patch is a lab-grown heart muscle made up of induced pluripotent stem cell-derived heart cells ... established by simulation of the clinical treatment in rhesus macaques.

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

By Mohana Ravindranath The promise of stem cell therapy is powerful ... that have been reprogrammed into blank cells and then into heart cells may be able to restore some cardiac function.